Business Context and Reporting Period
Company: BranchOut Food Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 15, 2024 (Signed July 19, 2024)
Reporting Period: Specific event date of July 15, 2024.
Context: The Company, an emerging growth company listed on the Nasdaq Capital Market (Symbol: BOF), entered into material definitive agreements to secure financing through a convertible note and a unit offering to officers and affiliates.
Key Financial Metrics and Transaction Details
This filing details a capital raise rather than periodic financial performance metrics (revenue, profit, cash flow). Key transaction figures include:
- Convertible Note Financing:
- Principal Amount: Up to $3,400,000 total.
- Initial Loan: $2,000,000.
- Additional Loan: Up to $1,400,000 (subject to conditions).
- Interest Rate: 12% per annum.
- Conversion Price: $0.7582 per share of Common Stock.
- Maturity: December 31, 2025, or earlier upon specific equity/debt sales or change of control.
- Warrants Issued (Convertible Note):
- 1,000,000 shares at $1.00 exercise price.
- 500,000 shares at $1.50 exercise price.
- Expiration: December 31, 2025.
- Unit Offering (Officers/Affiliates):
- Total Proceeds: $525,000.
- Structure: Units consisting of 100 shares of Common Stock and a warrant for 125 shares.
- Unit Price: $75.82 per Unit.
- Warrant Exercise Price: $1.00 per share (10-year term).
- Collateral: The Convertible Note is secured by a lien on substantially all of the Company's assets.
Material Changes and Conditions
The filing reports the entry into new material agreements rather than changes in historical financial performance. Key conditions and changes include:
- Investor Change: On July 19, 2024, the investor under the Securities Purchase Agreement was amended from Daniel L. Kaufman to Kaufman Kapital LLC.
- Conditions for Additional Funding: The remaining $1,400,000 of the Convertible Note is contingent upon:
- EnWave Corporation completing the manufacture of a new dehydration machine for the Company.
- The Company's manufacturing facility in Peru exporting product expected to generate at least $100,000 in revenue.
- Shareholder Approval Requirement: Conversion of the Note and exercise of Warrants are restricted until the Company obtains shareholder approval under Nasdaq Listing Rules 5635(b) and 5635(d) to prevent the investor from acquiring more than 19.9% of outstanding shares.
- Registration Rights: The Company must register the underlying shares upon demand once the investor holds at least 2,000,000 shares of Common Stock.
Outlook, Risks, and Management Commentary
Management Commentary: The Company is actively pursuing capital to support operations and expansion, evidenced by the secured financing and internal investment by the CEO, CFO, and other officers.
Risks and Contingencies:
- Dilution Risk: Significant potential dilution exists upon conversion of the note and exercise of warrants, subject to shareholder approval.
- Operational Contingency: Access to the full $3.4 million credit facility depends on third-party manufacturing completion (EnWave) and specific export revenue targets in Peru.
- Liquidity Constraints: The note is secured by substantially all company assets, limiting future borrowing capacity against those assets.
- Regulatory Hurdles: The ability to convert debt to equity or exercise warrants is delayed pending shareholder votes required by Nasdaq rules.
Investor Verification Checklist
- Verify the status of the shareholder vote required under Nasdaq Listing Rules 5635 to enable conversion and warrant exercise.
- Confirm the progress of EnWave Corporation in manufacturing the dehydration machine required to unlock the additional $1.4 million funding.
- Review the specific terms of the Security Agreement to understand the scope of assets pledged as collateral.
- Monitor the Company's Peru facility export volumes to determine if the $100,000 revenue threshold is met.
- Check for any subsequent filings regarding the registration rights demand once the investor holds 2,000,000 shares.